
Pipfastta 4000mg/500mg Injection
Marketer
Mepro Pharmaceuticals
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Pipfastta 4000mg/500mg Injection
Combifast 4000 mg/500 mg Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by healthcare providers, its dosage and frequency are tailored by your physician to your condition's severity. Strict adherence to prescribed usage is essential. Commonly reported side effects encompass nausea, vomiting, diarrhea, and skin rashes, along with potential injection site reactions such as pain, swelling, or inflammation. Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, kidney, or liver ailments; your doctor may adjust the dosage or select an alternative medication. Under medical guidance, this injection is generally considered safe for pregnant and breastfeeding individuals.
Uses of Pipfastta 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Pipfastta 4000mg/500mg Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
Common Side effects of Pipfastta 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Pipfastta 4000mg/500mg Injection:
This medication will be administered by your physician or registered nurse; please do not attempt self-medication.
How Pipfastta 4000mg/500mg Injection works:
Pipfastta, a 4000 mg/500 mg injectable formulation, unites piperacillin, a potent antibiotic, with tazobactam, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactam's role is to counteract bacterial resistance mechanisms, thereby optimizing piperacillin's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Pipfastta 4000 mg/500 mg Injection presents no adverse reactions.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Pipfastta 4000 mg/500 mg Injection is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to offspring; clinical data in humans, however, remains scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Pipfastta, 4000 mg/500 mg, presents no known breastfeeding contraindications. Research in humans indicates minimal drug transfer to breast milk, posing negligible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Pipfastta 4000 mg/500 mg Injection on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with impaired kidney function, the administration of Pipfastta 4000 mg/500 mg Injection requires careful monitoring. Dosage modification of Pipfastta 4000 mg/500 mg Injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Pipfastta 4000 mg/500 mg Injection in individuals with hepatic impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Pipfastta 4000mg/500mg Injection :
Omit a Pipfastta 4000 mg/500 mg Injection dose? Seek your physician's advice.
Facts to Know About Pipfastta 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Anti-Infectives |
